Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$3.80−0.10 (-2.56%)
Close on Nov 19, 2026Market cap $92.06MP/E –Yield –
Exagen shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Exagen's shares outstanding was 24M at Jun 30, 2026. For fiscal 2025 it was 22M, up 18.4% from the year before. The highest annual figure on record is 22M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 22M | +18.4% |
| FY2024 | Dec 31, 2024 | 18M | +3.0% |
| FY2023 | Dec 31, 2023 | 18M | +3.5% |
| FY2022 | Dec 31, 2022 | 17M | +7.0% |
| FY2021 | Dec 31, 2021 | 16M | +26.4% |
| FY2020 | Dec 31, 2020 | 13M | +253.0% |
| FY2019 | Dec 31, 2019 | 4M | +5580.1% |
| FY2018 | Dec 31, 2018 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 24M | +14.6% |
| Q1 FY2026 | Mar 31, 2026 | 24M | +28.5% |
| Q4 FY2025 | Dec 31, 2025 | 24M | +28.0% |
| Q3 FY2025 | Sep 30, 2025 | 23M | +25.7% |
| Q2 FY2025 | Jun 30, 2025 | 21M | +16.0% |
| Q1 FY2025 | Mar 31, 2025 | 19M | +3.4% |
| Q4 FY2024 | Dec 31, 2024 | 18M | +3.3% |
| Q3 FY2024 | Sep 30, 2024 | 18M | +3.2% |
| Q2 FY2024 | Jun 30, 2024 | 18M | +3.0% |
| Q1 FY2024 | Mar 31, 2024 | 18M | +2.4% |
| Q4 FY2023 | Dec 31, 2023 | 18M | +3.7% |
| Q3 FY2023 | Sep 30, 2023 | 18M | +3.6% |
| Q2 FY2023 | Jun 30, 2023 | 18M | +3.5% |
| Q1 FY2023 | Mar 31, 2023 | 18M | +3.1% |
| Q4 FY2022 | Dec 31, 2022 | 17M | +1.3% |
| Q3 FY2022 | Sep 30, 2022 | 17M | +0.8% |
| Q2 FY2022 | Jun 30, 2022 | 17M | +0.8% |
| Q1 FY2022 | Mar 31, 2022 | 17M | +31.3% |
| Q4 FY2021 | Dec 31, 2021 | 17M | +34.2% |
| Q3 FY2021 | Sep 30, 2021 | 17M | +34.0% |
| Q2 FY2021 | Jun 30, 2021 | 17M | +34.0% |
| Q1 FY2021 | Mar 31, 2021 | 13M | +2.8% |
| Q4 FY2020 | Dec 31, 2020 | 13M | +736.1% |
| Q3 FY2020 | Sep 30, 2020 | 13M | +19954.5% |
| Q2 FY2020 | Jun 30, 2020 | 13M | +19954.7% |
| Q1 FY2020 | Mar 31, 2020 | 13M | +19891.6% |
| Q3 FY2019 | Sep 30, 2019 | 2M | +2301.7% |
| Q2 FY2019 | Jun 30, 2019 | 0M | – |
| Q1 FY2019 | Mar 31, 2019 | 0M | – |
| Q4 FY2018 | Dec 31, 2018 | 0M | – |
| Q3 FY2018 | Sep 30, 2018 | 0M | – |
See a number that looks wrong?